Overview
Joining Ironwood Cancer & Research Centers in 2004, Dr. Shtivelband received his medical degree and PhD in Experimental Hematology in Russia. After Internal Medicine Residency, Dr. Shtivelband received fellowship training in Hematology and Medical Oncology at MD Anderson Cancer Center in Houston, where he stayed for an additional year to participate in experimental research. Treating patients with all kinds of malignancies and benign hematological problems, Dr. Shtivelband has particular interest in developing research programs to bring the newest advances in the field of Oncology and Hematology to our community. Dr. Shtivelband also heads the Ironwood Cancer & Research Center's research program. He is Board Certified in Internal Medicine, Hematology and Medical Oncology.
Dr. Shtivelband is rated as an Experienced provider by MediFind in the treatment of Omenn Syndrome. His top areas of expertise are Hemochromatosis, Non-Small Cell Lung Cancer (NSCLC), Plasmacytoma, and Lung Cancer.
His clinical research consists of co-authoring 13 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
Accepted plan types not found. Please verify directly with the provider.
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE PDP
- OTHER MEDICARE
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
695 S Dobson Rd, Chandler, AZ 85224
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
10 Clinical Trials
Arizona Oncology Associates, PC
Tania Cortas is a Hematologist in Phoenix, Arizona. Dr. Cortas is rated as an Advanced provider by MediFind in the treatment of Omenn Syndrome. Her top areas of expertise are Anal Cancer, Myelodysplastic Syndrome (MDS), Familial Colorectal Cancer, and Colorectal Cancer. Dr. Cortas is currently accepting new patients.
Arizona Center For Cancer Care
Dr. Roberts has been treating patients in Arizona for over 20 years and is board certified in medical oncology and hematology. Dr. Roberts is a member of the American College of Physicians, American Society of Internal Medicine, and American Society of Clinical Oncologists. He provides advanced high-quality compassionate cancer care in a community setting. Dr. Roberts has a special interest in treating patients with lung, breast, colon, prostate, and hematologic malignancies. He is a member of the American College of Physicians, American Society of Internal Medicine, and American Society of Clinical Oncologists. Dr. Roberts has been recognized as a top doctor in PHOENIX magazine and a super doctor in Phoenix, and has been recognized by the Leukemia Lymphoma Society (LLS) and the American Society of Clinical Oncology (ASCO). He received a teaching excellence award from St. Joseph's hospital and has received numerous other nationally recognized physician awards. Dr. Roberts has extensive experience in research, serving as the principal investigator in more than 100 studies. He was a founding member of the Arizona Institute of Breast Health as well as the Center for Thoracic Disease.To help people achieve health for life. Dr. Roberts is rated as an Advanced provider by MediFind in the treatment of Omenn Syndrome. His top areas of expertise are Familial Colorectal Cancer, Familial Prostate Cancer, Follicular Lymphoma, and Paget Disease of the Breast.
Ironwood Physicians, PC
Dr. Kellogg has practiced with Ironwood Cancer & Research Centers as a partner since 1995. He is a graduate of Wayne State University School of Medicine and completed his residency and fellowship at Wayne State University Affiliated Hospitals. Prior to joining ICRC Dr. Kellogg was an Assistant Professor of Medicine at Wayne State University and the Detroit Medical Center working on the breast cancer service. While at the university, in addition to treating patients Dr. Kellogg was involved in conducting multiple clinical research studies. Dr. Kellogg was also Chief Medical Resident at Detroit Receiving Hospital. Dr Kellogg has been recognized by Phoenix Magazine as Top Doc. Dr. Kellogg is Board Certified in Internal Medicine with Specialty Board Certifications in Medical Oncology and Hematology and maintains an active practice concentrating on all types of adult cancers and blood disorders. Dr. Kellogg is rated as a Distinguished provider by MediFind in the treatment of Omenn Syndrome. His top areas of expertise are Breast Cancer, B-Cell Lymphoma, Paget Disease of the Breast, and Schnitzler Syndrome.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Shtivelband isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AstrocytomaDr. Shtivelband isDistinguished. Learn about Astrocytoma.
- Breast CancerDr. Shtivelband isDistinguished. Learn about Breast Cancer.
- Childhood Iron Deficiency AnemiaDr. Shtivelband isDistinguished. Learn about Childhood Iron Deficiency Anemia.
- EGFR Positive Lung CancerDr. Shtivelband isDistinguished. Learn about EGFR Positive Lung Cancer.
- HemochromatosisDr. Shtivelband isDistinguished. Learn about Hemochromatosis.
- Advanced
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Shtivelband isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisDr. Shtivelband isAdvanced. Learn about Agranulocytosis.
- AnemiaDr. Shtivelband isAdvanced. Learn about Anemia.
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Shtivelband isAdvanced. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Autoimmune Hemolytic AnemiaDr. Shtivelband isAdvanced. Learn about Autoimmune Hemolytic Anemia.
- Experienced
- Acute Hepatic Porphyria (AHP)Dr. Shtivelband isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Monoblastic Leukemia (AmoL)Dr. Shtivelband isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Mountain SicknessDr. Shtivelband isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with MaturationDr. Shtivelband isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myelomonocytic LeukemiaDr. Shtivelband isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Adult Immune ThrombocytopeniaDr. Shtivelband isExperienced. Learn about Adult Immune Thrombocytopenia.